Angelalign TechnologyFRA:77D 69 Days Payable is 27.44 as of Dec. 2025, which is 56% below its 10-year median of 62.32. GuruFocus rates FRA:77D with a GF Score™ of 69/100 and a GF Value™ of €11.62 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 794 Medical Devices & Instruments companies, Angelalign Technology ranks worse than 87.03% on this metric.
The historical rank and industry rank for Angelalign Technology's Days Payable or its related term are showing as below:
FRA:77D'
s Days Payable Range Over the Past 10 Years
Min: 27.43 Med: 62.32 Max: 169.09
Current: 28.67
During the past 8 years, Angelalign Technology's highest Days Payable was 169.09. The lowest was 27.43. And the median was 62.32.
FRA:77D's Days Payable is ranked worse than 87.03% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 67.97
vs FRA:77D: 28.67
Angelalign Technology Days Payable Historical Data
* Premium members only.
The historical data trend for Angelalign Technology's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:77D vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Angelalign Technology's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Angelalign Technology Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Angelalign Technology's Days Payable distribution charts can be found below:
* The bar in red indicates where Angelalign Technology's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Angelalign Technology's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Angelalign Technology (FRA:77D) has a Days Payable of 27.44 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Angelalign Technology and its competitors. This is 56% below median its historical median of 62.32. Over the past decade, Angelalign Technology's Days Payable has ranged from 27.43 to 169.09. According to the industry distribution chart, Angelalign Technology ranks #691 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 87%.
Is Angelalign Technology's Days Payable too high?
Angelalign Technology's current Days Payable of 27.44 is 56% below median its 10-year median of 62.32. Over the past 10 years, this metric has ranged from a low of 27.43 to a high of 169.09. The Medical Devices & Instruments industry median Days Payable is 67.97. Angelalign Technology's value of 27.44 is 59.6% below this industry median. Based on the distribution chart, Angelalign Technology ranks #691 out of 794 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Angelalign Technology has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Angelalign Technology's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Angelalign Technology ranks #691 out of 794 companies for Days Payable. This places Angelalign Technology in the lower half of its industry. The industry median Days Payable is 67.97. Angelalign Technology's value of 27.44 is 59.6% below this benchmark. Historically, Angelalign Technology's own Days Payable has ranged from 27.43 to 169.09 over the past decade. While the company's 10-year median is 62.32 vs. the industry median of 67.97, Angelalign Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.97, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Angelalign Technology's current Days Payable of 27.44 is 59.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Angelalign Technology and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Angelalign Technology's current Days Payable is 27.44, which is 56% below median its own 10-year median of 62.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Angelalign Technology stock overvalued right now?
Based on GuruFocus' analysis, Angelalign Technology (FRA:77D) is currently considered Significantly Undervalued. The stock's GF Value™ is €11.62, compared to a current price of €8.15 — trading 29.9% below its estimated fair value. The current Days Payable is 27.44, which is 56% below median its 10-year median of 62.32 and 59.6% below the Medical Devices & Instruments industry median of 67.97. Angelalign Technology's overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Angelalign Technology (FRA:77D), the current Days Payable is 27.44 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Angelalign Technology (FRA:77D) Overvalued in 2026?
Based on GuruFocus' analysis, Angelalign Technology stock appears to be undervalued.
The current stock price of €8.15 is trading 29.9% below its estimated GF Value™ of €11.62.
GuruFocus considers Angelalign Technology to be Significantly Undervalued.
Key valuation signals for FRA:77D:
Days Payable: 27.44 (56% below median its 10-year median of 62.32)
GF Value™: €11.62 vs. price of €8.15 (29.9% below fair value)
Industry Position: 59.6% below the Medical Devices & Instruments median (#691 of 794)
No single metric tells the full story. See the FRA:77D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Angelalign Technology Inc is an investment holding company. It is principally engaged in clear aligner treatment solutions, including treatment planning services, manufacturing, and marketing of clear aligners. The company provides dental professionals with self-developed digital orthodontic solutions. The company's Angelalign clear aligner system facilitates dental professionals throughout the entire clear aligner treatment process, including digitally-assisted case assessment support and treatment planning services, provide dental professionals with digitally-assisted case assessment support and treatment planning services, and helps dental professionals design, review, and modify treatment plans.
69GF Score
Get the complete analysis for FRA:77D
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:77D has been successfully added to your 
